Range
183.26 - 189.65
Vol / Avg.
310.8K/385.2K
Div / Yield
-
52 Wk
129.43 - 216.9
Mkt Cap
8.4B
Payout Ratio
-
Open
189.45
P/E
18.81
EPS
3.62
Shares
45M
Outstanding
45M
Total Float
44.2M
load more
Sector: Health Care.Industry: Biotechnology
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for pulmonary arterial hypertension largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Nearly all of its sales are generated within the United States. United also markets a pediatric oncology drug, but its focus largely remains in pulmonary hypertension.

Earnings

see more
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2022-02-23
REV
Q3 2021Est.ActualSurprise
EPS3.5904.160 0.5700
REV421.450M444.700M23.250M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

United Therapeutics Questions & Anwsers

Q

How do I buy United Therapeutics (UTHR) stock?

A

You can purchase shares of United Therapeutics (NASDAQ: UTHR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are United Therapeutics's (UTHR) competitors?

Q

What is the target price for United Therapeutics (UTHR) stock?

A

The latest price target for United Therapeutics (NASDAQ: UTHR) was reported by Argus Research on July 14, 2021. The analyst firm set a price target for 205.00 expecting UTHR to rise to within 12 months (a possible 10.22% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for United Therapeutics (UTHR)?

A

The stock price for United Therapeutics (NASDAQ: UTHR) is $185.99 last updated Fri Dec 03 2021 21:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does United Therapeutics (UTHR) pay a dividend?

A

There are no upcoming dividends for United Therapeutics.

Q

When is United Therapeutics (NASDAQ:UTHR) reporting earnings?

A

United Therapeutics’s $Q4 earnings are confirmed for after-market on February 23, 2022.

Q

Is United Therapeutics (UTHR) going to split?

A

There is no upcoming split for United Therapeutics.

Q

What sector and industry does United Therapeutics (UTHR) operate in?

A

United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.